-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Neutral on Sionna Therapeutics, Raises Price Target to $6

Benzinga·09/15/2026 13:36:54
Listen to the news
Wedbush analyst Laura Chico maintains Sionna Therapeutics (NASDAQ:SION) with a Neutral and raises the price target from $5 to $6.